Works matching IS 03618609 AND DT 2022 AND VI 97 AND IP 5

Results: 28
    1
    2
    3
    4
    5

    Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 5, p. 613, doi. 10.1002/ajh.26510
    By:
    • Pommert, Lauren;
    • Schafer, Eric S.;
    • Malvar, Jemily;
    • Gossai, Nathan;
    • Florendo, Ellynore;
    • Pulakanti, Kirthi;
    • Heimbruch, Katelyn;
    • Stelloh, Cary;
    • Chi, Yueh‐Yun;
    • Sposto, Richard;
    • Rao, Sridhar;
    • Huynh, Van Thu;
    • Brown, Patrick;
    • Chang, Bill H.;
    • Colace, Susan I.;
    • Hermiston, Michelle L.;
    • Heym, Kenneth;
    • Hutchinson, Raymond J.;
    • Kaplan, Joel A.;
    • Mody, Rajen
    Publication type:
    Article
    6

    Transient receptor potential channel vanilloid type 2 in red cells of cannabis consumer.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 5, p. E180, doi. 10.1002/ajh.26509
    By:
    • Flormann, Daniel;
    • Qiao, Min;
    • Murciano, Nicoletta;
    • Iacono, Giulia;
    • Darras, Alexis;
    • Hof, Sebastian;
    • Recktenwald, Steffen M.;
    • Rotordam, Maria Giustina;
    • Becker, Nadine;
    • Geisel, Jürgen;
    • Wagner, Christian;
    • von Lindern, Marieke;
    • van den Akker, Emile;
    • Kaestner, Lars
    Publication type:
    Article
    7
    8
    9
    10

    Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three‐factor model.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 5, p. E176, doi. 10.1002/ajh.26502
    By:
    • Molica, Stefano;
    • Giannarelli, Diana;
    • Visentin, Andrea;
    • Reda, Gianluigi;
    • Sportoletti, Paolo;
    • Frustaci, Anna Maria;
    • Chiarenza, Annalisa;
    • Ciolli, Stefania;
    • Vitale, Candida;
    • Laurenti, Luca;
    • De Paoli, Lorenzo;
    • Murru, Roberta;
    • Gentile, Massimo;
    • Moia, Riccardo;
    • Rigolin, Gian Matteo;
    • Levato, Luciano;
    • Giordano, Annamaria;
    • Del Poeta, Giovanni;
    • Stelitano, Caterina;
    • Deodato, Marina
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19

    A predictive algorithm for identifying children with sickle cell anemia among children admitted to hospital with severe anemia in Africa.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 5, p. 527, doi. 10.1002/ajh.26492
    By:
    • Olupot‐Olupot, Peter;
    • Connon, Roisin;
    • Kiguli, Sarah;
    • Opoka, Robert O.;
    • Alaroker, Florence;
    • Uyoga, Sophie;
    • Nakuya, Margret;
    • Okiror, William;
    • Nteziyaremye, Julius;
    • Ssenyondo, Tonny;
    • Nabawanuka, Eva;
    • Kayaga, Juliana;
    • Williams Mukisa, Cynthia;
    • Amorut, Denis;
    • Muhindo, Rita;
    • Frost, Gary;
    • Walsh, Kevin;
    • Macharia, Alexander W.;
    • Gibb, Diana M.;
    • Walker, A. Sarah
    Publication type:
    Article
    20

    Phase 2 studies of lenalidomide, subcutaneous bortezomib, and dexamethasone as induction therapy in patients with newly diagnosed multiple myeloma.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 5, p. 562, doi. 10.1002/ajh.26491
    By:
    • O'Gorman, Peter;
    • Laubach, Jacob P.;
    • O'Dwyer, Michael E.;
    • Krawczyk, Janusz;
    • Yee, Andrew J.;
    • Gilligan, Oonagh;
    • Cahill, Mary R.;
    • Rosenblatt, Jacalyn;
    • Quinn, John;
    • Murphy, Philip T.;
    • DiPietro, Heidi;
    • Perera, Meegahage Ratnakanthi;
    • Crotty, Gerard M.;
    • Cummings, Kristen;
    • Hayden, Patrick J.;
    • Browne, Paul;
    • Savell, Alexandra;
    • O'Leary, Hilary M.;
    • O'Keeffe, Denis;
    • Masone, Kelly
    Publication type:
    Article
    21

    High prevalence and inferior long‐term outcomes for TP53 mutations in therapy‐related acute lymphoblastic leukemia.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 5, p. E171, doi. 10.1002/ajh.26490
    By:
    • Pourhassan, Hoda;
    • Yang, Dongyun;
    • Afkhami, Michelle;
    • Pillai, Raju;
    • Ball, Brian;
    • Al Malki, Monzr;
    • Salhotra, Amandeep;
    • Ali, Haris;
    • Artz, Andrew;
    • Curtin, Peter;
    • Armenian, Saro;
    • Stein, Anthony;
    • Forman, Stephen J.;
    • Marcucci, Guido;
    • Pullarkat, Vinod;
    • Nakamura, Ryotaro;
    • Aldoss, Ibrahim
    Publication type:
    Article
    22

    Persistence of Ad26.COV2.S‐associated vaccine‐induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 5, p. 519, doi. 10.1002/ajh.26488
    By:
    • Kanack, Adam J.;
    • Singh, Bandana;
    • George, Gemlyn;
    • Gundabolu, Krishna;
    • Koepsell, Scott A.;
    • Abou‐Ismail, Mouhamed Yazan;
    • Moser, Karen A.;
    • Smock, Kristi J.;
    • Green, David;
    • Major, Ajay;
    • Chan, Clarence W.;
    • Wool, Geoffrey D.;
    • Reding, Mark;
    • Ashrani, Aneel A.;
    • Bayas, Antonios;
    • Grill, Diane E.;
    • Padmanabhan, Anand
    Publication type:
    Article
    23
    24

    Anti‐CD19 and anti‐BCMA CAR T cell therapy followed by lenalidomide maintenance after autologous stem‐cell transplantation for high‐risk newly diagnosed multiple myeloma.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 5, p. 537, doi. 10.1002/ajh.26486
    By:
    • Shi, Xiaolan;
    • Yan, Lingzhi;
    • Shang, Jingjing;
    • Kang, Liqing;
    • Yan, Zhi;
    • Jin, Song;
    • Zhu, Mingqing;
    • Chang, Huirong;
    • Gong, Feiran;
    • Zhou, Jiazi;
    • Chen, Guanghua;
    • Pan, Jinlan;
    • Liu, Dandan;
    • Zhu, Xiaming;
    • Tang, Fang;
    • Liu, Minghong;
    • Liu, Wei;
    • Yao, Feirong;
    • Yu, Lei;
    • Wu, Depei
    Publication type:
    Article
    25
    26

    Long‐term follow‐up of 415 patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide‐based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials: A comprehensive assessment of prognostic factors.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 5, p. E168, doi. 10.1002/ajh.26483
    By:
    • Allsup, David John;
    • Craig, Zoe;
    • Cairns, David;
    • Howard, Dena;
    • Hockaday, Anna;
    • Bloor, Adrian;
    • Soe, Zarni;
    • Pepper, Christopher;
    • Gattei, Valter;
    • Zucchetto, Antonella;
    • Robbe, Pauline;
    • Clifford, Ruth;
    • Schuh, Anna;
    • Munir, Talha;
    • Rawstron, Andrew;
    • Hillmen, Peter
    Publication type:
    Article
    27
    28

    Issue Information.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 5, p. 511, doi. 10.1002/ajh.26222
    Publication type:
    Article